These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 11025697

  • 1. Early complications of endoscopic treatment for superficial bladder tumors.
    Collado A, Chéchile GE, Salvador J, Vicente J.
    J Urol; 2000 Nov; 164(5):1529-32. PubMed ID: 11025697
    [Abstract] [Full Text] [Related]

  • 2. Does the management of bladder perforation during transurethral resection of superficial bladder tumors predispose to extravesical tumor recurrence?
    Skolarikos A, Chrisofos M, Ferakis N, Papatsoris A, Dellis A, Deliveliotis C.
    J Urol; 2005 Jun; 173(6):1908-11. PubMed ID: 15879773
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The actual incidence of bladder perforation following transurethral bladder surgery.
    Balbay MD, Cimentepe E, Unsal A, Bayrak O, Koç A, Akbulut Z.
    J Urol; 2005 Dec; 174(6):2260-2, discussion 2262-3. PubMed ID: 16280794
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: results of a small series and a review of the literature.
    Mydlo JH, Weinstein R, Shah S, Solliday M, Macchia RJ.
    J Urol; 1999 Apr; 161(4):1128-32. PubMed ID: 10081853
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The value of a second transurethral resection in evaluating patients with bladder tumors.
    Herr HW.
    J Urol; 1999 Jul; 162(1):74-6. PubMed ID: 10379743
    [Abstract] [Full Text] [Related]

  • 9. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy?
    Herr HW, Donat SM, Dalbagni G.
    J Urol; 2007 Jan; 177(1):75-9; discussion 79. PubMed ID: 17162005
    [Abstract] [Full Text] [Related]

  • 10. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?
    Brauers A, Buettner R, Jakse G.
    J Urol; 2001 Mar; 165(3):808-10. PubMed ID: 11176474
    [Abstract] [Full Text] [Related]

  • 11. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
    Yang TB, Zeng FH, Sun ZQ.
    Chin Med J (Engl); 2006 Nov 05; 119(21):1821-8. PubMed ID: 17097038
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Transurethral electrovaporization of bladder cancer.
    McKiernan JM, Kaplan SA, Santarosa RP, Te AE, Sawczuk IS.
    Urology; 1996 Aug 05; 48(2):207-10. PubMed ID: 8753730
    [Abstract] [Full Text] [Related]

  • 15. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.
    J Urol; 2008 Nov 05; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [Abstract] [Full Text] [Related]

  • 16. Transurethral en bloc resection of bladder tumors.
    Saito S.
    J Urol; 2001 Dec 05; 166(6):2148-50. PubMed ID: 11696724
    [Abstract] [Full Text] [Related]

  • 17. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy.
    Herr HW.
    J Urol; 2005 Dec 05; 174(6):2134-7. PubMed ID: 16280743
    [Abstract] [Full Text] [Related]

  • 18. The frequency of hydronephrosis at initial diagnosis and its effect on recurrence and progression in patients with superficial bladder cancer.
    Divrik RT, Sahin A, Altok M, Unlü N, Zorlu F.
    J Urol; 2007 Sep 05; 178(3 Pt 1):802-6; discussion 806. PubMed ID: 17632171
    [Abstract] [Full Text] [Related]

  • 19. Long-term benefit of 5-aminolevulinic acid fluorescence assisted transurethral resection of superficial bladder cancer: 5-year results of a prospective randomized study.
    Daniltchenko DI, Riedl CR, Sachs MD, Koenig F, Daha KL, Pflueger H, Loening SA, Schnorr D.
    J Urol; 2005 Dec 05; 174(6):2129-33, discussion 2133. PubMed ID: 16280742
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.